Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2025 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2025 Earnings Call Transcript May 8, 2025Pacira BioSciences, Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:PCRX’
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics...
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2024 Earnings Call Transcript February 27, 2025Pacira BioSciences, Inc. beats earnings expectations.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2024 Earnings Call Transcript November 6, 2024Pacira BioSciences, Inc. beats earnings expectations.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2024 Earnings Call Transcript July 30, 2024Pacira BioSciences, Inc. beats earnings expectations.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript
Pacira BioSciences, Inc. misses on earnings expectations. Reported EPS is $0.62 EPS, expectations were $0.64.
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
In this article, we will take a look at aggressive stock portfolio: 13 stocks picked by analysts.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcript
Pacira BioSciences, Inc. reports earnings inline with expectations. Reported EPS is $0.89 EPS, expectations were $0.89. Pacira BioSciences, Inc.
Hedge Funds are Betting on These 14 Sliding Stocks
In this article, we will take a look at the hedge funds that are betting on these 14 sliding stocks.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q3 2023 Pacira BioSciences Earnings Conference Call.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Q2, 2023 Pacira BioSciences Inc. Earnings Conference Call.
5 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the five best small cap pharma stocks to buy.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q1 2023 Pacira BioSciences Inc Earnings Conference Call. All participants are in a listen-only mode.
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Quarter Four 2022 Pacira BioSciences, Inc. Earnings Conference Call.
Here’s What Makes Pacira BioSciences (PCRX) a Great Buy
Carillon Tower Advisers, an investment management firm, published its “Carillon Scout Small Cap Fund” first quarter 2022 investor letter – a copy of which can be downloaded...
Billionaire John Paulson’s Latest Portfolio: Top 10 Stock Picks
In this article, we discuss the top 10 stock picks of billionaire John Paulson’s latest portfolio.
Hedge Funds Are Crazy About Pacira Biosciences Inc (PCRX)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
15 Best Stocks to Buy for 2022 According to Analysts
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Hedge Funds Are Coming Back To Pacira Biosciences Inc (PCRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Stocks to Buy According to John Paulson
In this article, we will discuss the 10 best stocks to buy according to John Paulson.
Hedge Fund Sentiment Is Stagnant On Pacira Biosciences Inc (PCRX)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity...
Here is What Hedge Funds Think About Pacira Biosciences Inc (PCRX)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
In this article you are going to find out whether hedge funds think Pacira Biosciences Inc (NASDAQ:PCRX) is a good investment right now.
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
We hate to say this but, we told you so.
2019 Review: Top Hedge Fund Stocks vs. Pacira BioSciences, Inc. (PCRX)
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Is Pacira BioSciences, Inc. (PCRX) A Good Stock To Buy?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Is Pacira BioSciences, Inc. (PCRX) A Good Stock To Buy?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.
Here’s What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the...
Is Pacira Pharmaceuticals Inc (PCRX) A Good Stock To Buy ?
Before we spend countless hours researching a company, we'd like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Pacira Pharmaceuticals Inc (PCRX): Are Hedge Funds Right About This Stock?
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track ...
13G Filing: Point72 Asset Management and Pacira Pharmaceuticals Inc. (PCRX)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent...
13G Filing: Healthcor Management LP and Pacira Pharmaceuticals Inc. (PCRX)
You can access the original SEC filing by clicking here.
13G Filing: Partner Fund Management and Pacira Pharmaceuticals Inc (PCRX)
You can access the original SEC filing by clicking here.
Should You Buy Pacira Pharmaceuticals Inc (PCRX)?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
Should You Be Bullish on Home Bancshares Inc (HOMB), Calpine Corporation (CPN) & Two Other Stocks?
Are Home Bancshares Inc (NASDAQ:HOMB), Calpine Corporation (NYSE:CPN), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), and Rent-A-Center Inc (NASDAQ:RCII) stocks that should be ...
Mattress Firm (MFRM) Acquisition Powers 40 North Management to Impressive Q3 Returns
David S. Winter and David J. Millstone's 40 North Management is one of the 749 hedge funds in our database that filed a 13F for the June 30 SEC reporting period.
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Here’s Why CareDx Inc (CDNA), Netflix Inc. (NFLX) and Three Other Stocks Are Losing Ground Today
Markets are strong today, ahead of an important two-day policy meeting of the US Fed.
A Look at Visium Asset Management’s Top Picks Amid Loud Insider Trading Case
Jacob Gottlieb’s multi-billion-dollar hedge fund Visium Asset Management LP has been making headlines earlier today, as federal authorities filed criminal and civil securities...
Hedge Funds Hated These Healthcare Stocks in Q1
The healthcare sector is down by about 3.75% so far this year, after enjoying a lengthy bull run into the middle of 2015.
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate...
Should You Buy Pacira Pharmaceuticals Inc (PCRX)?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
A Look at 5 Major Stock Market Gainers and the Drivers Behind Their Sharp Uptrend
As stock markets are trading in a narrow range with a slight negative bias today, five stocks are showing significant upside price movement backed by high volumes.
Four Hot Biotechs Among The Day’s Big Winners
On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks are making strong gains...
Goldman Sachs And Hedge Funds See Big Things For These Small-caps
The recent pull back in the Russell 2000 index left it down about 10% on a year-to-date basis just before the start of this month.
What Hedge Funds Think Of Goldman Sachs’ Top Healthcare Takeover Targets
A surge of M&A activity involving healthcare, financial, and retail companies boosted the value of deals in July to over $430 billion, resulting in the seventh-busiest month ...
Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)
According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.
